Water Loss in the Skin of Pediatric Eczema Patients Request More Information Trial Objective Researchers are studying how much water is lost in the skin of pediatric atopic dermatitis patients (eczema) before and after using the medication dupilumab, the generic form of Dupixent®. Pediatric patients without eczema are needed, too. Patient’s skin will be tested through the use of skin tape, a circular, slightly sticky disk that is placed on the skin and removed to collect skin cell samples. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Pediatric patients with moderate to severe atopic dermatitis (eczema) and those without eczema. Age: 6-12 Gender: Any Gender Estimated Time Commitment Up to 12 visits over 8 months Including a 4-month treatment period for atopic dermatitis (eczema) participants. × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Trish Taylor 303.398.1409 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors Sanofi Principal Investigators Donald Leung, PhD, MD + × Donald Leung, PhD, MD Professor Head, Division of Pediatric Allergy & Immunology Department of Pediatrics View Full Profile Make an Appoinment Request More Information By completing this form, you agree to learn more about this study, see if you qualify and receive periodic updates about clinical research via email. First Name:* Last Name:* Email Address:* Phone:*
Trial Objective Researchers are studying how much water is lost in the skin of pediatric atopic dermatitis patients (eczema) before and after using the medication dupilumab, the generic form of Dupixent®. Pediatric patients without eczema are needed, too. Patient’s skin will be tested through the use of skin tape, a circular, slightly sticky disk that is placed on the skin and removed to collect skin cell samples.